$114.51▴ 1.26%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
VanEck Pharmaceutical ETF's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
1 bullish1 neutral0 bearish
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH?
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?